Pens' Malkin Making The Best Of Things: Evgeni Malkin is tied with Boston's David Krejci for the playoff scoring race with 13 points (3 G, 10 A) after a two-point night Tuesday. (Updated 5/15/13)
Injury Report
No information available at this time (Updated 5/22/13).
Fantasy Analysis
He's skating as well as he has all season long. Evgeni Malkin is still battling through an injured left shoulder which may require offseason surgery, however, making his slap shot much less of a weapon. Even so, he's able to create offensive opportunities with his strong skating. Malkin skated less than 16 minutes (15:56) as Pittsburgh spent considerable time killing off five Ottawa power plays. (Updated 5/15/13).
05/20/2013 08:00 The power play that doomed the Penguins in Game 3
The Penguins had a chance to push the Senators to the brink of elimination. Instead, one power play allowed Ottawa to stay in the series.
05/19/2013 23:51 Senators get back into series with Pens in dramatic fashion
Colin Greening scored 7:39 into double overtime, and the Ottawa Senators rallied for a 2-1 victory over the Pittsburgh Penguins that cut their series deficit to 2-1 on Sunday night.
When knee problems forced Evgeni Malkin out for a two-week stretch in October, fantasy owners likely cringed. The Penguins forward played well in the preseason and had showed no signs of injury -- and then Wham! Fortunately, his absence turned out to be just seven games and, when he returned there was no one better. Malkin won the Hart Trophy and his second Art Ross Trophy, finishing with 50 goals and 109 points. He led the league in shots (339) and finished second in power-play points with 34 (12G, 22A). The Penguins center averaged 1.45 points per game; 1.59 points with Sidney Crosby in the lineup -- including 16 goals in 22 games -- and 1.40 without Crosby. Fantasy poolies who include shootout statistics will want to take note of Malkin's 8-for-11 conversion rate, as well. The dynamic duo of Malkin and James Neal combined for 90 goals, and, while that number might be difficult to duplicate, expect big things again in 2012-13 from Geno. (Updated 8/14/12)
